About Zhejiang Hisun Pharmaceuticals
Zhejiang Hisun Pharmaceuticals is a company based in Taizhou (China) founded in 1956.. The company has 7,990 employees as of December 31, 2024. Zhejiang Hisun Pharmaceuticals offers products and services including Raw Drugs and Formulations.
- Headquarter Taizhou, China
- Employees 7990 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Zhejiang Hisun Pharmaceutical Co., Ltd. Class A
-
Annual Revenue
$1.33 B (USD)-5.92as on Dec 31, 2024
-
Net Profit
$82.36 M (USD)745.25as on Dec 31, 2024
-
EBITDA
$247.97 M (USD)35.37as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
7990
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Zhejiang Hisun Pharmaceuticals
Zhejiang Hisun Pharmaceuticals is a publicly listed company on the SSE with ticker symbol 600267 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Zhejiang Hisun Pharmaceuticals
Zhejiang Hisun Pharmaceuticals offers a comprehensive portfolio of products and services, including Raw Drugs and Formulations. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Raw drugs are manufactured for use in various treatments, including antineoplastic and cardiovascular applications
Formulations are developed for immune and metabolic therapies, among others
Funding Insights of Zhejiang Hisun Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Zhejiang Hisun Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Zhejiang Hisun Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Zhejiang Hisun Pharmaceuticals Comparisons
Competitors of Zhejiang Hisun Pharmaceuticals
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Zhejiang Hisun Pharmaceuticals
Frequently Asked Questions about Zhejiang Hisun Pharmaceuticals
When was Zhejiang Hisun Pharmaceuticals founded?
Zhejiang Hisun Pharmaceuticals was founded in 1956.
Where is Zhejiang Hisun Pharmaceuticals located?
Zhejiang Hisun Pharmaceuticals is headquartered in Taizhou, China. It is registered at Taizhou, Jiangsu, China.
Who is the current CEO of Zhejiang Hisun Pharmaceuticals?
Bai Hua is the current CEO of Zhejiang Hisun Pharmaceuticals.
How many employees does Zhejiang Hisun Pharmaceuticals have?
As of Dec 31, 2024, the latest employee count at Zhejiang Hisun Pharmaceuticals is 7,990.
What is the annual revenue of Zhejiang Hisun Pharmaceuticals?
Annual revenue of Zhejiang Hisun Pharmaceuticals is $1.33B as on Dec 31, 2024.
What does Zhejiang Hisun Pharmaceuticals do?
Founded in 1956 and based in Taizhou, China, the company operates in the pharmaceutical sector. Active pharmaceutical ingredients, formulations, and animal health products are produced through a vertically integrated process that covers research, manufacturing, and distribution. Research and development efforts focus on chemical, biological, and traditional Chinese medicines, leading to innovative drug launches. Products are distributed both domestically and internationally, with adherence to global quality standards maintained.
What products or services does Zhejiang Hisun Pharmaceuticals offer?
Zhejiang Hisun Pharmaceuticals offers Raw Drugs and Formulations.
Is Zhejiang Hisun Pharmaceuticals publicly traded?
Yes, Zhejiang Hisun Pharmaceuticals is publicly traded on SSE under the ticker symbol 600267.
What is Zhejiang Hisun Pharmaceuticals's ticker symbol?
The ticker symbol of Zhejiang Hisun Pharmaceuticals is 600267 on SSE.